
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Autophagy, cancer stem cells and drug resistance
Alexandra G. Smith, Kay F. Macleod
The Journal of Pathology (2018) Vol. 247, Iss. 5, pp. 708-718
Open Access | Times Cited: 324
Alexandra G. Smith, Kay F. Macleod
The Journal of Pathology (2018) Vol. 247, Iss. 5, pp. 708-718
Open Access | Times Cited: 324
Showing 1-25 of 324 citing articles:
Autophagy in major human diseases
Daniel J. Klionsky, Giulia Petroni, Ravi K. Amaravadi, et al.
The EMBO Journal (2021) Vol. 40, Iss. 19
Open Access | Times Cited: 1068
Daniel J. Klionsky, Giulia Petroni, Ravi K. Amaravadi, et al.
The EMBO Journal (2021) Vol. 40, Iss. 19
Open Access | Times Cited: 1068
EMT, cancer stem cells and autophagy; The three main axes of metastasis
Ghader Babaei, Shiva Gholizadeh‐Ghaleh Aziz, Nasrin Zare Zavieyh Jaghi
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110909-110909
Open Access | Times Cited: 401
Ghader Babaei, Shiva Gholizadeh‐Ghaleh Aziz, Nasrin Zare Zavieyh Jaghi
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110909-110909
Open Access | Times Cited: 401
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Vivek Panwar, Aishwarya Singh, Manini Bhatt, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 312
Vivek Panwar, Aishwarya Singh, Manini Bhatt, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 312
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 308
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 308
Sarcoma treatment in the era of molecular medicine
Thomas G. P. Grünewald, Marta M. Alonso, Sofia Avnet, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 11
Open Access | Times Cited: 242
Thomas G. P. Grünewald, Marta M. Alonso, Sofia Avnet, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 11
Open Access | Times Cited: 242
Mitophagy in tumorigenesis and metastasis
Logan P. Poole, Kay F. Macleod
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 8, pp. 3817-3851
Open Access | Times Cited: 169
Logan P. Poole, Kay F. Macleod
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 8, pp. 3817-3851
Open Access | Times Cited: 169
Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance
Chaochu Cui, Jianbo Yang, Li Xiao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 165
Chaochu Cui, Jianbo Yang, Li Xiao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 165
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
Maria Laura De Angelis, Federica Francescangeli, Ann Zeuner
Cancers (2019) Vol. 11, Iss. 10, pp. 1569-1569
Open Access | Times Cited: 149
Maria Laura De Angelis, Federica Francescangeli, Ann Zeuner
Cancers (2019) Vol. 11, Iss. 10, pp. 1569-1569
Open Access | Times Cited: 149
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 131
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 131
The multifaceted role of autophagy in cancer
Ryan C. Russell, Kun‐Liang Guan
The EMBO Journal (2022) Vol. 41, Iss. 13
Open Access | Times Cited: 130
Ryan C. Russell, Kun‐Liang Guan
The EMBO Journal (2022) Vol. 41, Iss. 13
Open Access | Times Cited: 130
Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress
Olivier D. Christophe, Lisa Oliver, Lisenn Lalier, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 128
Olivier D. Christophe, Lisa Oliver, Lisenn Lalier, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 128
Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 62
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 62
Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations
Christina G. Towers, Darya Wodetzki, Andrew Thorburn
The Journal of Cell Biology (2019), pp. jcb.201909033-jcb.201909033
Open Access | Times Cited: 121
Christina G. Towers, Darya Wodetzki, Andrew Thorburn
The Journal of Cell Biology (2019), pp. jcb.201909033-jcb.201909033
Open Access | Times Cited: 121
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications
Huibin Song, Dongcheng Liu, Shaowei Dong, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 104
Huibin Song, Dongcheng Liu, Shaowei Dong, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 104
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 5, pp. 963-974
Open Access | Times Cited: 91
Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 5, pp. 963-974
Open Access | Times Cited: 91
Targeting cancer stem cells in drug discovery: Current state and future perspectives
Fangyu Du, Qifan Zhou, Wenjiao Sun, et al.
World Journal of Stem Cells (2019) Vol. 11, Iss. 7, pp. 398-420
Open Access | Times Cited: 89
Fangyu Du, Qifan Zhou, Wenjiao Sun, et al.
World Journal of Stem Cells (2019) Vol. 11, Iss. 7, pp. 398-420
Open Access | Times Cited: 89
Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells
Malini Visweswaran, Frank Arfuso, Sudha Warrier, et al.
Stem Cells (2019) Vol. 38, Iss. 1, pp. 6-14
Open Access | Times Cited: 88
Malini Visweswaran, Frank Arfuso, Sudha Warrier, et al.
Stem Cells (2019) Vol. 38, Iss. 1, pp. 6-14
Open Access | Times Cited: 88
Autophagy: Supporting cellular and organismal homeostasis by self-eating
Eeva‐Liisa Eskelinen
The International Journal of Biochemistry & Cell Biology (2019) Vol. 111, pp. 1-10
Open Access | Times Cited: 87
Eeva‐Liisa Eskelinen
The International Journal of Biochemistry & Cell Biology (2019) Vol. 111, pp. 1-10
Open Access | Times Cited: 87
Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research
Lejia Sun, Huayu Yang, Yanan Wang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 85
Lejia Sun, Huayu Yang, Yanan Wang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 85
Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients
José M. Ayuso, Marı́a Virumbrales-Muñoz, Patrick H. McMinn, et al.
Lab on a Chip (2019) Vol. 19, Iss. 20, pp. 3461-3471
Open Access | Times Cited: 84
José M. Ayuso, Marı́a Virumbrales-Muñoz, Patrick H. McMinn, et al.
Lab on a Chip (2019) Vol. 19, Iss. 20, pp. 3461-3471
Open Access | Times Cited: 84
Mechanisms of enzalutamide resistance in castration‐resistant prostate cancer and therapeutic strategies to overcome it
Yuanyuan Wang, Jiyuan Chen, Zhengjie Wu, et al.
British Journal of Pharmacology (2020) Vol. 178, Iss. 2, pp. 239-261
Open Access | Times Cited: 83
Yuanyuan Wang, Jiyuan Chen, Zhengjie Wu, et al.
British Journal of Pharmacology (2020) Vol. 178, Iss. 2, pp. 239-261
Open Access | Times Cited: 83
Crosstalk between autophagy and metabolic regulation of cancer stem cells
Mouradi El Hout, Emma Cosialls, Maryam Mehrpour, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 81
Mouradi El Hout, Emma Cosialls, Maryam Mehrpour, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 81
A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
Lori J. Goldstein, Raymond P. Perez, Denise A. Yardley, et al.
Breast Cancer Research (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Lori J. Goldstein, Raymond P. Perez, Denise A. Yardley, et al.
Breast Cancer Research (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Circular RNAs in drug resistant tumors
Xin Hua, Yue Sun, Jing Chen, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109233-109233
Open Access | Times Cited: 79
Xin Hua, Yue Sun, Jing Chen, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109233-109233
Open Access | Times Cited: 79
Role of Mitochondria in Cancer Stem Cell Resistance
José Manuel García-Heredia, Amancio Carnero
Cells (2020) Vol. 9, Iss. 7, pp. 1693-1693
Open Access | Times Cited: 79
José Manuel García-Heredia, Amancio Carnero
Cells (2020) Vol. 9, Iss. 7, pp. 1693-1693
Open Access | Times Cited: 79